Intervention

Oxycodone

ClinicalTrials.gov intervention label

Clinical trials5

Recruiting1

Common conditions13

Lead sponsors shown4

Clinical trials

5 shown

Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity SurgeryNCT03756961 · 2019-05-01

Opioid-Free Pain Control Regimen Following Robotic Radical ProstatectomyNCT05597878 · 2023-04-18

ESP in Breast Surgery Due to CancerNCT04726878 · 2021-02-01

To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer PainNCT02321397 · 2014-11-01

A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer PainNCT00513656 · 2007-09-01

Common conditions

Anesthesia, Local1 Breast Cancer1 Cancer1 Constipation1 Malignant Pain1 Non-malignant Pain1 Obesity1 Opioid Use1 Pain1 Pain Management1 Pain, Acute1 Pain, Postoperative1 Prostate Cancer1

Leading sponsors

Mundipharma Research GmbH & Co KG2 Göteborg University1 Medical University of Lublin1 Wake Forest University Health Sciences1

Trial status mix

COMPLETED3

RECRUITING1

TERMINATED1

Phase mix

PHASE23

PHASE32

NA1

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.